Home/Filings/4/0001104659-17-052710
4//SEC Filing

Doman Timothy A 4

Accession 0001104659-17-052710

CIK 0001639947other

Filed

Aug 17, 8:00 PM ET

Accepted

Aug 18, 5:36 PM ET

Size

21.3 KB

Accession

0001104659-17-052710

Insider Transaction Report

Form 4
Period: 2017-08-17
Doman Timothy A
DirectorVice President
Transactions
  • Disposition to Issuer

    Common Stock

    2017-08-17116,5020 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2017-08-1713,5420 total
    Exercise: $27.07Exp: 2022-03-09Common Stock (13,542 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2017-08-1750,5560 total
    Exercise: $29.57Exp: 2024-03-07Common Stock (50,556 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2017-08-1785,5540 total
    Exercise: $29.94Exp: 2026-01-27Common Stock (85,554 underlying)
  • Award

    Common Stock

    2017-08-17+14,768116,502 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2017-08-1711,2330 total
    Exercise: $27.95Exp: 2021-02-25Common Stock (11,233 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2017-08-1729,6320 total
    Exercise: $34.37Exp: 2023-03-08Common Stock (29,632 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2017-08-1759,4940 total
    Exercise: $34.16Exp: 2025-03-06Common Stock (59,494 underlying)
Footnotes (6)
  • [F1]Pursuant to an Agreement and Plan of Merger, dated May 7, 2017 (the "Merger Agreement"), by and among Sabra Health Care REIT, Inc., a Maryland corporation ("Sabra"), Sabra Health Care Limited Partnership, a Delaware limited partnership, PR Sub, LLC, a Delaware limited liability company and wholly owned subsidiary of Sabra ("Merger Sub"), Care Capital Properties, Inc., a Delaware corporation (the "Issuer"), and Care Capital Properties, LP, a Delaware limited partnership, the outstanding performance-based restricted stock units held by the Reporting Person immediately prior to the effective time of the merger (the "Merger") of Issuer with and into Merger Sub vested in full and were converted into an aggregate 14,768 shares of Issuer common stock.
  • [F2]Pursuant to the Merger Agreement, each outstanding share of the Issuer's common stock was exchanged on August 17, 2017 for the right to receive 1.123 newly issued shares of Sabra's common stock (the "Merger Consideration"), subject to certain adjustments as set forth in the Merger Agreement. The closing price of shares of Sabra's common stock on August 16, 2017 was $21.72 per share.
  • [F3]Fully vested.
  • [F4]A portion of these options were scheduled to vest on March 6, 2018.
  • [F5]These options were granted on January 27, 2016 and were scheduled to vest in three equal installments beginning on the first anniversary of the date of the grant.
  • [F6]Pursuant to the Merger Agreement, each stock option, whether vested or unvested, that was outstanding and unexercised immediately prior to the effective time of the Merger vested in full (if not already vested), was assumed by Sabra and was converted into a stock option award to purchase a number of shares of Sabra common stock, at an exercise price per share of Sabra common stock under such option, based on the exchange ratio provided in the Merger Agreement, and will remain exercisable in accordance with the terms and conditions applicable to the original stock option.

Documents

1 file

Issuer

Care Capital Properties, Inc.

CIK 0001639947

Entity typeother

Related Parties

1
  • filerCIK 0001388433

Filing Metadata

Form type
4
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 5:36 PM ET
Size
21.3 KB